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MouseThe cranial base is essential for integrated craniofacial development and growth. It develops as a cartilaginous
template that is replaced bybone through the process of endochondral ossiﬁcation. Here,we describe a novel and
speciﬁc role for the homeoprotein Six2 in the growth and elongation of the cranial base. Six2-null newbornmice
display premature fusion of the bones in the cranial base. Chondrocyte differentiation is abnormal in the Six2-null
cranial base, with reduced proliferation and increased terminal differentiation. Gain-of-function experiments
indicate that Six2 promotes cartilage development and growth in other body areas and appears therefore to
control general regulators of chondrocyte differentiation. Our data indicate that the main factors restricting Six2
function to the cranial base are tissue-speciﬁc transcription of the gene and compensatory effects of other Six
family members. The comparable expression during human embryogenesis and the high protein conservation
from mouse to human implicate SIX2 loss-of-function as a potential congenital cause of anterior cranial base
defects in humans.an Sciences, AV Hill Building,
.
(N. Bobola).
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The cranial base is part of the neurocranium, which surrounds and
protects the brain. It develops as a cartilaginous template that is
replaced by bone through the endochondral ossiﬁcation process, when
chondrocytes proliferate, secrete abundant extracellular matrix and
terminate their differentiation process reaching the hypertrophic stage;
thereafter, cells undergo apoptosis, blood invasion occurs and cartilage
is eventually replaced by bone. Transition of the cells through these
differentiation steps is strictly controlled both temporally and spatially
(Wagner and Karsenty, 2001).
Ossiﬁcation centers ﬁrst emerge within the cartilage of the cranial
base posteriorly and then anteriorly. Thebasioccipital ossiﬁcation center
is the ﬁrst to appear starting at embryonic day 14 (E14) in mouse,
followed by the basisphenoid and ﬁnally the presphenoid, formed
between E16 and E17 (Shum et al., 2003). The cartilage segments
separating these ossiﬁcation centers are referred to as synchondroses.
Analogous to the growth plate of long bones, synchondroses allow the
rapid endochondral growth of the bone and eventually close when thebone reaches its ﬁnal size. Moreover, chondrocytes in synchondroses
and in the growth plate of long bones are distributed into resting,
proliferating and hypertrophic zones. However, as a result of two
hypertrophic and proliferating zones ﬂanking a central resting zone,
synchondroses produce a bidirectional growth with cartilage in the
center and bone at each end, in contrast to the unidirectional growth
from the growth plate of long bones.
The cranial base is essential for integrated craniofacial development
and growth (Nie, 2005; Opperman et al., 2005). It has a dual embryonic
origin, with its anterior portion deriving from cranial neural crest, while
paraxialmesoderm forms the posterior one. These two embryonic tissues
integrate to form the basisphenoid bone, which has a mixed embryonic
origin. Defects that disrupt the growth and development of the cranial
base result in phenotypes associatedwith several craniofacial syndromes,
including achondroplasia, Apert syndrome, cleidocranial dysplasia,
Crouzon syndrome and mandibulofacial dysostosis (Horowitz, 1981;
Jensen and Kreiborg, 1993; Kjaer et al., 2001; Kreiborg et al., 1993;
Peterson-Falzone and Figueroa, 1989; Tokumaru et al., 1996). In addition,
malformations in the cranial base may be secondary to defects in the
growth and development of other craniofacial skeletal and soft tissue
structures, especially the cranial sutures, which develop in close
associationwith the cranial base (Mooney et al., 1993; Perlyn et al., 2001).
Development and patterningof the cranial basedependon anumber
of transcription factors, amongwhich Otx2, Gli2, Mfh1 and members of
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1993; Iida et al., 1997; Matsuo et al., 1995; Mo et al., 1997; Rijli et al.,
1993). It is also controlled by members of key signaling pathways in
craniofacial development, such as retinoic acid receptors (Lohnes et al.,
1994; Mendelsohn et al., 1994) and platelet-derived growth factor
(PDGF) receptor (Soriano, 1997). Endochondral bone formation in the
cranial base is generally assumed tobe controlledby the samemolecular
mechanisms that regulate development of the appendicular skeleton.
Members of the Bmp family of proteins regulate chondrocyte
proliferation and differentiation in long bones, and Bmp4 promotes
chondrocyte proliferation and hypertrophy in the cranial base
(Ducy and Karsenty, 2000; Hoffmann and Gross, 2001; Shum et al.,
2003). Moreover, loss of function of chordin, an inhibitor of Bmp
signaling, causes cranial base defects (Bachiller et al., 2003). Mutations
in Fgfrs, ﬁbroblast growth factor receptors, have been shown to lead to
craniosynostosis and short limb skeletal dysplasia in humans (Rice et al.,
2003), with some of these mutations primarily affecting cranial base
growth (Chen et al., 1999; Chen et al., 2001; Eswarakumar et al., 2002).
Similarly mice with loss of function of Ihh, a gene that regulates
chondrocyte differentiation in the growth plate, display abnormal
development of the synchondroses (Lanske et al., 1996; Vortkamp et al.,
1996; Young et al., 2006). However, few studies have speciﬁcally
explored the genetics of cranial base development and growth. The
identiﬁcation of cranial base-speciﬁc signaling pathways is essential in
understanding the mechanisms of development, evolution and role in
human disorders of this structure.
The sine oculis/Six family of genes encode for six transcription factors
in vertebrates (Kawakami et al., 2000). Six proteins share a conserved
homeodomain and a Six domain and can at least partially substitute for
each other in vivo and in vitro (Ando et al., 2005; Giordani et al., 2007;
Grifone et al., 2005). Six genes are diversely expressed during vertebrate
embryogenesis and control the formation of various organs. In most
cases, they positively regulate cells numbers within the developing
embryo by promoting cell proliferation and/or survival and mainly act
as transcription factors (Christensen et al., 2008; Kawakami et al., 2000).
Six proteins act synergisticallywith Pax and Eya proteins in a regulatory
network ﬁrst identiﬁed in Drosophila as essential for compound eye
formation. Six2 is required for kidney development, where it maintains
the renal progenitor cell population in an undifferentiated state
(Self et al., 2006). Six2 is also necessary for the formation of the pyloric
sphincter (Self et al., 2009).
In this study, we describe a novel and speciﬁc role for Six2 in the
development of the anterior cranial base. Six2-null newborn mice
exhibit a shorter cranial base, where the bones are prematurely fused.
Analysis of Six2-null mice shows that Six2 controls chondrocyte
differentiation by promoting cell proliferation and preventing matura-
tion into hypertrophic chondrocytes. Gain-of-function experiments
show that Six2 similarly controls endochondral bone formation in other
body areas, indicating that Six2 effects are likely to target general
regulators of cartilage growth and differentiation. Tissue-speciﬁc
transcription and compensatory effects from other Six genes restrict
the Six2-null phenotype to the presphenoid component of the cranial
base. The comparable expression during human embryogenesis makes
SIX2 a candidate for mutation in human disorders of this region of the
cranial base.
Materials and methods
In situ hybridization and histological analysis
In situ hybridization was performed as described (Kanzler et al.,
1998), using Six2 (Oliver et al., 1995),H4C (Young et al., 2006), ColX and
ColI probes (a kind gift fromChristineHartmann) and osteopontin (a gift
from Ray Boot-Handford). TRAP staining was performed using a
commercial acid phosphatase leukocyte kit (Sigma, St Louis, MO).
Alcian blue staining of tissue sections was carried out as described(Pearse, 1968). For whole mount analyses, E18.5 embryos and
newborns were eviscerated, skinned and ﬁxed. Following ﬁxation,
cartilages were stained with Alcian blue and bones with alizarin red, as
described (Mallo and Brandlin, 1997).
Mutant animals and microarray analyses
Animals experimentswere carriedoutunderASPA1986. Six2andSix1;
Six4-nullmutantmice have been described (Self et al. 2006; Grifone et al.,
2005, respectively). Transient transgenic embryos expressing the Hoxa2-
Six2 transgene (abbreviated to a2-Six2) are described in Kutejova et al.,
2005. Forelimbs of wild-type and transgenic E10.5 embryos analyzed by
Affymetrix technology were derived from crossing a transgenic founder
with no apparent phenotypic defects, which transmitted the a2-Six2
transgene to the F2, causing perinatal lethality and the skeletal defects
expected by overexpression of Six2 (Kutejova et al., 2005). Dissected
forelimbs were immediately frozen in liquid nitrogen. After genotyping
the embryos, two poolsweremade of wild-type and transgenic forelimbs
and total RNAwas extracted fromeachusing Trizol. Processing of the RNA
and hybridization to Affymetrix 430A microarrays was performed
according to the manufacturer's recommendations.
Human embryo collection and processing
Ethical approval for the studies was granted by the North West
Regional Ethics Committee. Human embryos were collected with
informed consent under guidelines issued by the UK Government
Polkinghorne Committee, ﬁxed, embedded and sectioned as described
previously (Hanley et al., 2008; Piper et al., 2004).
Results
Craniofacial abnormalities in Six2-null mice
Six2-null mice die at birth (Self et al., 2006) and are easily
distinguishable from their heterozygous and wild-type littermates by
their abnormal head shape.
Skulls from wild-type and Six2-null newborns were stained with
Alcian blue andAlizarin red to visualize cartilage and bone, respectively.
Themutant skulls appeared compressed as comparedwith thewild type
(Figs. 1A, B). A ventral view of the wild-type cranial base revealed
basioccipital, basisphenoid and presphenoid bones well separated by
cartilage segments, whereas no cartilage segments between the
basioccipital and basisphenoid bones and between the basisphenoid
and presphenoid bones were seen in Six2-null newborns (Figs. 1C, D).
The abnormal growth of the cranial base in the mutant did not affect
formation of the palate, located below the anterior portion of the cranial
base (not shown). The shorter appearance of Six2-null skulls is entirely
caused by the premature fusion of the bones in the cranial base, as the
mutant mandible developed correctly (Figs. 1E, F).
The nasal bones were present but appeared delayed in develop-
ment in Six2-null compared to wild-type (not shown). The rest of the
skull (skull vault, occipital and parietal regions) developed normally.
Third and fourth branchial arch-derived cartilages were hypomor-
phic in Six2-null newborns. The thyroid cartilage was smaller and the
inferior horns failed to extend as they did in the wild type (Figs. 1G, H,
arrow). The cricoid cartilage was also smaller in Six2-null newborns
and its dorsal components did not form (not shown).
Six2-null newborns did not display any of the craniofacial defects
of Six1−/− and Six1;Six4−/− (e.g. shorter mandible, absence of the
retro-tympanic process of the temporal bones, poorly developed otic
capsule with malformations in the associated middle ear ossicles)
(Grifone et al., 2005; Laclef et al., 2003). However, mild defects in ﬁrst
and second branchial arch derivatives of Six2-nulls were observed
with incomplete penetrance and included malformation of the styloid
Fig. 1. Craniofacial phenotype of Six2-null newborns. Skeletal preparation of wild-type (A, C, E, G) and Six2-null (B, D, F, H) newborns. Lateral view of the wild-type head (A) and the
Six2-null shorter head (B). Ventral view of the wild-type (C) and Six2-null (D) head shows absent intrasphenoidal and reduced spheno-occipital synchondrosis (white arrows
between presphenoid and basisphenoid bones and basisphenoid and basioccipital bones, respectively) in the mutant. Palatal bones and mandible were removed to expose the
cranial base. Mandibles isolated from wild-type (E) and Six2-null (F) newborns. Thyroid cartilages isolated from wild-type (G) and Six2-null (H) newborns; arrow indicates the
inferior horn of the thyroid cartilage. PS, presphenoid; BS, basisphenoid; BO basioccipital bones.
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(1/5 and 2/5 Six2-null newborns respectively) (data not shown).
Six2-nulls display premature chondrocyte maturation
The cranial base is built as a cartilage template, which is replaced
by bone through the process of endochondral bone formation. In this
multi-step process, chondrocytes proliferate, exit the cell cycle,
undergo hypertrophy and ultimately die while invading osteoblasts
deposit a new, bone-speciﬁc matrix. The premature ossiﬁcation
observed in the Six2-null cranial base could be caused by disturbance
in any of the above steps; we analyzed earlier developmental stages to
determine the primary cause of the shorter cranial base of Six2-nulls.
Alcian blue staining of longitudinal sections of E16.5 wild-type and
mutant heads identiﬁed the developing presphenoid (PS) bone as the
elementmost affected (Figs. 2A, B), with a shorter cartilage precursor and
an expanded area of large hypertrophic cells in the mutant (Figs. 2C, D),
suggesting an accelerated cell differentiation process. In keeping with
these ﬁndings, the region positive for type X collagen (ColX) expression, a
marker of hypertrophic chondrocytes, was wider in the PS mutant
precursor (Figs. 2E, F). No obvious differences between wild-type and
mutant mice were observed in type I collagen (ColI) in situ hybridizationin the presphenoid bone precursor (Figs. 2G, H), suggesting that the
absence of Six2 does not affect early differentiation of osteoblasts. Finally,
Alizarin red staining revealed comparable ossiﬁcation in the E16.5 wild-
type and mutant cranial base; the basioccipital ossiﬁcation center was
visible, but no ossiﬁcation could be detected in the PS bone precursor,
suggesting the process of ossiﬁcation does not begin prematurely in Six2-
nulls (Figs. 2I, L). Once chondrocytes become hypertrophic, they are fated
for rapid cell death and replacement by bone (de Crombrugghe et al.,
2001). One day later (E17.5), ossiﬁcation was detected in the wild-type
and mutant anterior cranial base, as revealed by the presence of ColI-
positive osteoblast cells (Figs. 3C,D). As a result of the expandeddomainof
hypertrophic cartilage observed earlier, a larger area of the Six2-null
anterior cranial base underwent ossiﬁcation compared towild-type. Six2-
null osteoblasts correctly expressed osteopontin and revealed alkaline
phosphatase activity (Figs. 3F,H). Osteoclasts, identiﬁed by tartrate
resistant acid phosphatase (TRAP) activity, were present in the area
undergoing ossiﬁcation in wild-type and mutant anterior cranial base
(Figs. 3I,L).
These observations indicate that the extensive ossiﬁcation observed
in the Six2-null cranial base is caused by an abnormal chondrocyte
differentiation, leading to expanded areas of hypertrophic cartilage
(ready for bone replacement). Despite the increased size of the areas
Fig. 2. Premature chondrocyte differentiation in Six2-nulls. Adjacent parasagittal sections from E16.5 wild-type (A, C, E, G) and Six2-null (B, D, F, H) mice were stained with Alcian
blue (A–D) and analyzed for ColX (E,F) and ColI (G,H) expression by in situ hybridization. (A, B) Sections show the entire cranial base. (C–H) Higher magniﬁcation of wild-type and
mutant presphenoid bone precursor. (C, D) A larger area of hypertrophic cells (arrowheads) is present in Six2-null presphenoid precursor. (E, F) ColX expression identiﬁes large cells
as hypertrophic chondrocytes. (G, H) Blue staining (ColI) around the edge of the PS bone precursor corresponds to the area undergoing ossiﬁcation. PS, presphenoid; BO, basioccipital
bones; P, pituitary gland. (I, L) Alizarin red-stained skeletal preparation of E16.5 wild-type (I) and Six2-null (L) embryos. The basioccipital ossiﬁcation center is enclosed in a dotted
circle. Arrowheads mark the expected position of the PS ossiﬁcation center. M, mandibular bone; P, palatal bone.
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normal in the absence of Six2.
The absence of Six2 reduces chondrocyte proliferation
The increased number of mature cells observed in the PS region of
Six2-nulls at E16.5 may reﬂect an overall acceleration of the process of
endochondral bone formation. To verify this possibility, we followed
endochondral bone formation from its early stages.
Alcian blue staining of E13.5 wild-type and Six2-null cranial base
outlined early, weakly stained PS chondrogenic condensations, as the
process of matrix deposition is still in progress at this stage
(compare Figs. 4A, B with the more robust staining observed 1 day later
in Figs. 4E, F). The size of the PS condensations and the deposition of
extracellular matrix appeared comparable in wild-type and Six2-null
embryos (Figs. 4A, B). Similarly, analysis of proliferating cells, based on
expression of H4C, a universal marker of proliferating cells (Young et al.,
2006), displayed no signiﬁcant difference between the wild and themutant PS chondrogenic condensations (meanpercentageof proliferating
cells was 13% and 11% in the wild-type and mutant PS precursor
respectively; P not signiﬁcant) (Figs. 4C, D), suggesting early stages of
endochondral bone formation are not affected in Six2-null embryos.
One day later (E14.5), analysis of proliferating cells revealed the
earliest observable difference between the wild-type and the Six2-null
cranial base. A signiﬁcant reduction in the number of proliferating
cells was detected in Six2-null PS precursor compared to wild type
(Figs. 4G,H,Q). TheE14.5wild-typeand Six2-null PSprecursordisplayeda
similar morphology (Fig. 4E, F) and, as expected for this developmental
stage (Shum et al., 2003), no differentiated ColX- positive cells were
detected in the E14.5 wild-type or mutant PS precursor. These cells were
only detected in the basioccipital precursor in the posterior cranial base
(not shown).
Alcian blue staining of E15.5 presumptive PS bones revealed few
morphological differences between wild-type and Six2-null embryos
at this stage. The mutant PS bone appeared wider, displayed a slight
increase in large hypertrophic chondrocytes (Figs. 4K, L), and the
Fig. 3. Ossiﬁcation in Six2-nulls. Adjacent parasagittal sections from E17.5 wild-type (A, C, E, G, I) and Six2-null (B, D, F, H, L) anterior cranial base were stained with Alcian blue (A,B)
and analyzed for ColI expression (C,D), alkaline phosphatase activity (E,F), osteopontin expression (G,H) and TRAP activity (I,L). (A, B) Cartilage is almost completely absent in the
mutant PS, with the exception of small isolated areas (black arrow). (C, D) A wider domain of ossiﬁcation, marked by ColI-positive cells, is present in Six2-null PS precursor
(arrowheads). (E–H) Alkaline phosphatase activity and osteopontin expression are detected in osteoblasts (arrowheads) and terminally differentiated chondrocytes (left right
arrow). (I, L) TRAP-positive osteoclasts are detected in the areas undergoing ossiﬁcation in both the wild-type and mutant anterior cranial base (dark brown precipitates in I, L). Nc,
nasal cartilages; P, pituitary gland.
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as compared to the wild-type (Figs. 4M, N). Analysis of the number of
proliferating cells at E15.5 identiﬁed H4C-expressing cells only in the
anterior third of the PS bone precursor in the mutant embryo but in
the anterior two-thirds of the corresponding wild-type structure
(Figs. 4O, P, Q). In addition, in the wild-type PS precursor, the area
occupied by proliferating cells extended to the area harboring ColX-
expressing mature cells, whereas the mutant structure showed an
Alcian blue-stained area that was neither H4C- nor ColX-positive, in
which cells stopped proliferation but did not proceed to differentiate
(Figs. 4O, P). The expanded area of hypertrophic chondrocytes
observed in the E16.5 PS bone precursor (Figs. 2E, F) suggests that
these cells enter premature differentiation. The distribution of TUNEL-
positive cells was similar in the wild-type and mutant Six2-null PS
precursor at this or at an earlier stage (E14.5), indicating that
increased cell death does not contribute to the shorter cranial base of
Six2-null (data not shown).
These data show that at early stages (E14.5),whennomorphological
differences between the wild-type and mutant bone precursors are
detected, the pool of proliferating chondrocytes is considerably reduced
in the Six2-null PS precursor. Given that chondrocyte proliferation and
maturation are tightly coupled processes (Sorrentino et al., 1990; Tao
and Umek, 2000; Umek et al., 1991), the increased number of maturecells observed in the PS regionof Six2-nulls at E16.5may arise secondary
to a deranged proliferation. Thus, defective chondrocyte proliferation
appears to be the primary cause of the shorter cranial base in Six2-null
mice.
How is Six2 function restricted to the PS precursor?
Tissue-speciﬁc transcription represents an important mechanism in
spatially restricting the function of a protein. In an effort to clarify how
Six2 function is restricted to the anterior cranial base, we investigated
the distribution of Six2 expression in the developing head region. At
E13.5, Six2 expressionwas detected in the nasal epithelia and cartilages,
pituitary gland and in the PS and basisphenoid bone precursors as well
as in the Meckel cartilage and the thymus (Fig. 5A). At E14.5 Six2-
expressing cells were still present in the mid-posterior region of the PS
(Fig. 5B, arrowheads) and labeled mostly the outer sides in the anterior
region (Fig. 5B). The presence of proliferating, H4C-expressing cells in
themid-posterior region of the PS bone precursor (Fig. 5C, arrowheads;
see also Fig. 5G) supports the possibility of a direct effect of Six2 on
cell proliferation.
Thedata above suggest that SIX2 is an excellent candidate formutation
as the underlying cause of human cranial base congenital defects. To
further investigate this possibility, we examined SIX2 expression in the
Fig. 4. Decreased chondrocyte proliferation in Six2-null PS precursor. Adjacent parasagittal sections of wild-type (A, C, E, G, K, M, O) and Six2-nulls (B, D, F, H, L, N, P) anterior cranial bases were stained with Alcian blue (A,B, E,F, K, L) and
analyzed for H4C (C, D, G, H, O, P) and ColX (M,N) expression by in situ hybridization. At E13.5 (A–D) wild-type andmutant appear similar by Alcian blue staining (A, B) and H4C expression (C, D, arrowheads). E14.5 (E–H). Alcian blue staining
reveals a comparable morphology in wild-type (E) and mutant (F); H4C expression by in situ hybridization reveals a reduction in proliferating cells in the mutant (G, arrowheads) compared to the wild-type (H, arrowheads). E15.5 (K–P).
Alcian blue staining and ColX expression demarcate a slightly larger area of hypertrophy in the mutant (L, N) than in the wild-type (K, M). Proliferating cells, marked by H4C expression, occupy a considerably larger portion of the PS precursor
in wild-type (O, arrowheads) than in the mutant (P, arrowheads). The mutant PS exhibits an area (red arrows) negative for both H4C and ColX. P, pituitary gland. Q: Quantiﬁcation of proliferating cells within the PS precursor of E14.5 and E
15.5 wild-type (red) andmutant (blue) embryos. Proliferating cells are expressed as the ratio ofH4C-expressing cells within the total number of cells counted in the PS precursor. Data represent themean percentage of 7 independent sections
of the PS precursor, derived from at least 2 different embryos for each genotype and each embryonic stage.
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Fig. 5. Six2 expression in the head region. Parasagittal sections from E13.5 (A) and E14.5 (B, C) wild-type embryo analyzed for Six2 (A, B) and H4C (C) gene expression by in situ
hybridization. (A) Six2-positive cells are present in the nasal cartilages and epithelia, the pituitary gland, the PS precursor, the otic capsule, the basisphenoid bone precursor, the
Meckel cartilage and the thymus. (B) Higher magniﬁcation of Six2 expression in the E14.5 PS precursor. Six2-expressing cells are detected in the mid-posterior region of the PS
(Fig. 4B, arrowheads) and mostly at the outer sides in the anterior region of the PS. (C) Adjacent section to B hybridized with H4C probe to identify H4C-positive, proliferating cells
(marked by arrowheads). bs, basisphenoid; M, Meckel cartilage; ne, nasal epithelia; nc, nasal cartilages; oc, otic capsule; p, pituitary gland; ps, presphenoid; t, thymus.
726 G. He et al. / Developmental Biology 344 (2010) 720–730developing human embryo at 48 days post-conception (dpc; Carnegie
stage 19) chosen to correspond to E13–13.5 of mouse development. SIX2
transcripts were apparent in the anterior cranial base with detection
concentrated in the sphenoid precursor (Fig. 6B, arrowheads). SIX2
expression was also detected in the pituitary gland (Fig. 6B).
Six2 has a general effect on endochondral bone formation
In a previous study to examine the role of Six2 in the generation of
the Hoxa2 mutant phenotype (Kutejova et al., 2005), we showed that
Six2 overexpression directed by the Hoxa2 enhancer (Nonchev et al.,
1996) resulted in the formation of ectopic cartilage, with abnormal
elongation of the lesser horn of the hyoid bone and the styloid process,
e.g. the cartilages patterned by Hoxa2. Here we show that the enhancer
also directs Six2 expression in the forelimbs and the somitic mesoderm
(Figs. 7A, B) in addition to the expected ectopic expression in the second
branchial arch. Skeletal preparation of E18.5 transgenic embryos
overexpressing Six2 revealed an abnormal phenotype in the forelimbs
(6/10 transgenic embryos). Consistentwith thedetection of ectopic Six2
in the anterior limb bud (Fig. 7B, arrow), the radius was the most
affected element, being shorter and displaying failure of ossiﬁcation
(Figs. 7C, D; n=6). In the embryos with the most extreme phenotype,
the humerus was also shorter (Fig. 7D; n=3) and formation of ectopic
cartilage was detected (Fig. 7D, arrow; n=2). Delayed ossiﬁcation was
also observed in the vertebral bodies (Figs. 7E, F; n=3), consistentwith
Six2 overexpression in the somites.
These effects are opposite to those observed in the cranial base of
Six2-null mice. Six2 gain-of-function halts the replacement of cartilageFig. 6. SIX2 is expressed in the sphenoid precursor. Parasagittal adjacent sections from
48 dpc human embryo HE stained (A) and analyzed for SIX2 gene expression by in situ
hybridization (B). (B) Higher magniﬁcation of the boxed area in A shows SIX2-positive
cells in the sphenoid bone precursor (arrowheads). P, pituitary gland.by bone, while its absence accelerates ossiﬁcation. High levels of Six2
induce the formation of ectopic cartilage in the forelimbs and expand
branchial arch cartilages, defects consistentwith enhanced chondrocyte
proliferation, while the absence of Six2 impairs proliferation of
chondrocytes in the PS precursor. These opposing phenotypes indicate
that Six2 function is not context speciﬁc but can generally affect growth
and development of cartilage in the endochondral skeleton.
Cranial base defects in Six1;Six4 double mutants
The increasing severity of compound mutants of Six genes indicate
that Six family members act redundantly. The craniofacial defects
observed upon inactivation of Six1, the closest homologue of Six2, are
enhanced in Six1;Six4 double mutants (Grifone et al., 2005). We
investigated whether skeletal preparations of E18.5 Six1;Six4-null
mice show a similar cranial base phenotype to Six2 mutant, as this
would suggest possible redundancy. Analysis of Six1;Six4-null heads
displayed an abnormal cranial base with premature fusion of the
exoccipital and basioccipital bones (Fig. 8B). Both basioccipital and
basisphenoid bones were malformed and displayed a partial unilateral
fusion. However, the presence of a large cartilage segment to separate
basisphenoid and presphenoid bones (Fig. 8B, arrow) indicates that
ossiﬁcation of this area occurs normally in the absence of Six1 and Six4
proteins. These ﬁndings indicate that Six2 controls development of the
anterior cranial base with no or little redundancy from other family
members and may help to explain the restricted phenotype, mainly
impacting the PS precursor, observed upon Six2 inactivation.
Discussion
The identiﬁcation of cranial base-speciﬁc pathways is essential to
clarify the mechanisms of cranial base development and the role of the
cranial base in human disorders. Here we uncover a new role for the
homeoprotein Six2 in the growth and development of the cranial base.
Six2-null newborns present a shorter cranial base due to a
premature fusion of the cranial bones. The defect is more accentuated
in the anterior part of the cranial base, with the phenotype originating
in the presphenoid bone precursor. Histological analysis shows a
normal cranial base in E13.5 Six2-null mutants, indicating that the
absence of Six2 does not affect early steps of cranial base develop-
ment, such as migration of cranial neural crest, and condensation and
differentiation of mesenchymal progenitors. Cell proliferation appears
normal in the E13.5 mutant PS chondrogenic condensation; 1 day
Fig. 7. Broad effect of Six2 on endochondral bone formation. (A) Expression of Six2 in E10.5 wt embryos. Six2 mRNA is not detected in the limb bud (arrow). (B) Six2 is ectopically
expressed in the anterior limb bud (arrow) and the somitic mesoderm of transgenic embryos. (C) Forelimb skeleton of E18.5 wt embryo. (D) Forelimb skeleton of a transgenic
littermate. The radius exhibits a complete lack of ossiﬁcation and an ectopic cartilage extends to the side of the hand (arrow). The ulna and the humerus are malformed. (E) Cervical
vertebrae of E18.5 wt embryo. The red dots in the wild-type vertebral bodies are areas of ossiﬁcation (arrow). (F) Cervical vertebrae of a Six2-overexpressing transgenic littermate, in
which ossiﬁcation is absent (arrow).
727G. He et al. / Developmental Biology 344 (2010) 720–730later, however, the pool of proliferating chondrocytes is drastically
reduced in the Six2-null PS precursor. Reduced proliferation is
followed at a later stage (E16.5) by an increased number of
chondrocytes entering terminal differentiation. After reaching termi-
nal differentiation, chondrocytes are physiologically fated for rapid
cell death and hypertrophic cartilage is replaced by bone (de
Crombrugghe et al., 2001). The abnormal chondrocyte differentiation
observed in the Six2-null cranial base may lead to more extensive
ossiﬁcation by expanding the areas of hypertrophic cartilage. As
cartilages are sites of active growth during endochondral ossiﬁcation,
their premature disappearance interferes with the correct elongation
of the cranial base and causes the fusion of the bones. Therefore,
accelerated chondrocyte differentiation may directly explain the
defects observed in the Six2-null cranial base.
Six2 may independently act to regulate proliferation ﬁrst and then
terminal differentiation of the cells into hypertrophic chondrocytes.
However, as chondrocyte proliferation and maturation are tightly
coupled processes (Sorrentino et al., 1990; Tao and Umek, 2000;
Umek et al., 1991), a primary defect in proliferation is likely to impact
on terminal differentiation. Thus, defective proliferation of chondro-
cytes within the presphenoid bone precursor appears to underlie the
shorter cranial base in Six2-null mice.
The failure of Six2-nulls to form kidneys reﬂects a depletion of
undifferentiated renal progenitors due to increased death and prema-
ture differentiation of these cells (Self et al., 2006). While cells in the
cranial base also differentiate prematurely, the earliest defect observed
in the cranial base is a change in the number of proliferating cells,
possibly leading to the premature differentiation. Furthermore,
increased cell death is not detected in the mutant cranial base. These
observations and the absence of proliferation defects in Six2-nullkidneys, suggest a different role for Six2 in the presphenoid bone
precursor than in the kidney.
Howdoes Six2 control growth anddevelopment of the PS bone?One
can envision two possible alternative scenarios. In the ﬁrst case, Six2
uniformly controls cell proliferation in the developing PS precursor. Its
absence generally decreases cell proliferation and accelerates terminal
differentiation of chondrocytes (this possibly as a secondary effect).
Proliferation and differentiation are abnormally uncoupled in the E15.5
mutant PS precursor, where cells are held in between the proliferative
and the differentiation step (Fig. 4P, red double arrow). Alternatively,
Six2may control cell proliferation, but only in a restricted area of the PS
bone precursor. At all the stages examined, starting from E14.5, defects
are consistently observed in the mid-posterior region of the PS
precursor. At E14.5, proliferating cells preferentially localize in the
mid-posterior region of the wild-type PS precursor, while very few cells
are dividing in the corresponding area of themutant. At E15.5, the same
area displays no proliferating cells in Six2-nulls, while a similar density
of proliferating cells is observed in the anterior area of the E15.5 wild-
type and mutant PS precursor (arguing against a general defect in
proliferation) (Fig. 4P, arrowheads). At E16.5, cells differentiate
prematurely in a corresponding mid-posterior position of the mutant
PS precursor. These observations suggest that cells in the mid-posterior
region of the PS precursor do not proliferate and enter terminal
differentiation prematurely in the absence of Six2. The hypothesis of a
spatially restricted defect within the PS precursor explains the presence
of cells held in between proliferation and terminal differentiation in
terms of a defective cell population within a unit (PS precursor), which
otherwise develops “normally”. In both cases (i.e., if Six2were to control
cell proliferation in the entire PS precursor or in a limited cell population
of the PS precursor), Six2 absence would eventually impact on the
Fig. 8. Cranial base phenotype of E18.5 Six1;Six4 double mutant. Skeletal preparation of
wild-type (A) and Six1;Six4 -null mutant (B). Ventral view of the head shows fusion
between the exoccipital and basioccipital bones (asterisks in B) and malformed
basioccipital and basisphenoid with partial unilateral fusion (arrowhead). Unlike
Six2-null, Six1;Six4 double mutant show a large intrasphenoidal synchondrosis (arrow).
In panel A, mandibles were removed to expose the cranial base.
728 G. He et al. / Developmental Biology 344 (2010) 720–730general growth of the PS bone, as the PS cartilage is spatially and
temporally organized into a functional unit.
Six2 is widely expressed in the E13.5 PS precursor, but at E14.5 Six2
expression is mainly detected in the mid-posterior region. Proliferating
cells are present in this area of the PS precursor at E14.5 and, as a
transcription factor, Six2 could directly control the proliferation of these
cells.
Some additional points remain open for discussion. Firstly, there is a
temporal delay between reduced cell proliferation, ﬁrst observed at
E14.5, and the change in size and morphology of the mutant PS
precursors, detected at E16.5. This can be explained by the observation
that the percentage of proliferating cells in the PS precursor increases
over development (with about 10% of the PS precursor cell population
proliferating at E14.5, followed by almost 25% at E15.5). Therefore,
although striking differences are observed in numbers of proliferating
cells between the E14.5 wild-type and mutant PS precursors, the
population of proliferating cells (affected in the mutant) may not be
large enough to have an immediate effect on the morphology of the
mutant PS precursor. Secondly, although Six2 is highly expressed in the
E13.5 precursor and proliferating cells are present at this stage, the
absence of Six2 appears not to affect cell proliferation until E14.5. One
can speculate that the presence of other genes, which control
development and growth of the PS precursor together with Six2, may
partially (before a certain stage) compensate Six2 absence. The
aforementioned possibility that Six2 may selectively control chondro-
cyte proliferation and differentiation in restricted areas of the PS
precursor, offers a possible explanation to the observed late onset of the
phenotype.To address the question of how Six2 controls chondrocyte
proliferation, we tested whether Six2 exerts a general effect on
endochondral bone formation or, instead, functions upstream of genes
selectively acting in the head. We found that overexpression of Six2
impacts the formation of cartilage in all the embryonic areas where
ectopic expressionwas observed and generates opposite effects to those
observed in the cranial baseof Six2-nullmice. This broad effect of Six2on
cartilage development and differentiation, together with the high
penetrance of the phenotype in transgenic embryos, strongly argues
against the possibility that Six2 effects are restricted to the cranial base
by regulation of genes speciﬁcally involved in the development of this
region. Instead, the ﬁndings suggest that Six2 directly controls general
regulators of chondrocyte differentiation. In these transgenic embryos,
Six2 ectopic expression does not persist throughout endochondral bone
formation. High and spatially restricted levels of Six2 are observed at
E10.5 and decline at E11.5. Considering that active chondrogenesis is in
progress throughout the embryo at E11.5 (Zhou et al., 1998), it is likely
that Six2 affects early stages of endochondral bone formation and that
the defective ossiﬁcation results from disturbing the onset of a process
relying on a series of tightly linked steps.
The phenotype of Six2-overexpressing transgenic embryos is similar
to that observedwhen Sox9, amaster regulator of cartilage and the gene
responsible for maintaining proliferating chondrocytes, is overex-
pressed in chondrocytes (Akiyama et al., 2004). Overexpression of
Sox9 delayed endochondral ossiﬁcation since bone formation from a
cartilage template requires that chondrocytes switch off Sox9 to become
hypertrophic and eventually die, thus allowingosteoblasts to invade the
cartilage and deposit bone matrix. Moreover, Sox9 overexpression
generated fusion of the hyoid to the styloid process, a defect similar to
the one observed in Six2-overexpressing transgenic embryos (Kutejova
et al., 2005). While the detection of Sox9 upregulation in Six2-
overexpressing embryos (NB, unpublished results) raises the possibility
that Six2 acts directly upstream of Sox9, increased Sox9 expression
might simply reﬂect the increase in the pool of proliferating chon-
drocytes upon Six2 overexpression. Indeedmeasurement of Sox9mRNA
levels in different cell lines upon overexpression of Six2 revealed no
change (KPH and NB, unpublished results), suggesting Sox9 is not a
direct mediator of Six2 function.
Based on previous ﬁndings linking Six2 and Six5 to the control of
Igf2 and Igfbp5 (Kutejova et al., 2008; Sato et al., 2002), we examined
the possibility that Six2 may control the IGF axis. We found that Igf2
expression is downregulated in the mutant PS precursor at E14.5,
when the cellular phenotype is ﬁrst observed. Igf2 was also detected
among the genes upregulated upon Six2 overexpression by expression
proﬁling of E10.5 wild-type and transgenic forelimb buds (NB,
unpublished results). Altogether these observations point at Igf2 as
a likely functional target of Six2 and further investigation will be
directed to establish its functional role downstream of Six2.
Finally, it has been recently reported that chondrocyte-speciﬁc,
conditional inactivation of Dicer, an essential component for the
biogenesis of small noncoding microRNAs (miRNAs), simultaneously
decreases chondrocyte proliferation and accelerates differentiation of the
cells into postmitotic hypertrophic chondrocytes (Kobayashi et al., 2008).
The cellular phenotype described in Dicer-null growth plates bears
similaritywith the one observed in the Six2-null cranial base, suggesting a
possible link between the molecular function of Six2 and the regulatory
mechanisms operated by miRNAs.
In contrast to the broad effect of Six2 overexpression on cartilage
development and differentiation, the absence of Six2 causes extremely
localized skeletal defects and affects only the growth and development
of the anterior cranial base and of the thyroid and cricoid cartilages. The
main factor responsible for spatially restricting Six2 function is its
limited transcription in the developing embryo. Thismechanism cannot
entirely account for Six2 localized function as Six2 is expressed in other
areas destined to form cartilages (Meckel, nasal and otic capsule,
basisphenoid precursor), which develop normally in its absence.
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most likely contributes to limiting Six2 function to speciﬁc areas of the
developingembryo. A redundant function of Six2 in the craniofacial area
is supported by the observation that Six2-null embryos display
incompletely penetrant defects in ﬁrst and second arch skeletal
structures, which are strongly affected in Six1 and Six1;Six4 mutants
(Grifone et al., 2005; Laclef et al., 2003). We have reported here that the
anterior cranial base develops normally in Six1;Six4mutants, indicating
that Six2 controls development of the anterior cranial base with no or
little redundancy fromother familymembers. This observation provides
anexplanation for the severephenotypeobserved in the anterior cranial
base upon Six2 inactivation. It should also be considered that the
anterior cranial base is cranial neural crest-derived, as opposed to the
mesoderm-derivedposterior cranial base. Thisheterogeneitymay result
in adifferent sensitivity to the absence of Six2of the anterior cranial base
versus the posterior cranial base, and eventually to the developmentof a
more severe phenotype.
The brachyrrhine (Br) mouse mutant, generated in a neutron
irradiation experiment (Searle, 1966), displays an abnormal growth
pattern of the skull in the anterior cranial base (Lozanoff et al., 1994).
Linkage analysis hasmapped theBrmutation in theproximityof the Six2
locus (Fogelgren et al., 2008). Although sequencing of the Six2 gene,
including the promoter region, did not identify any mutation, Six2
expression was found to be severely reduced in the Br mutant. In
contrast to the Six2-null mutant, whose presphenoid bone precursor
exhibits premature ossiﬁcation, the Br mutant phenotype is character-
ized by complete absence of the presphenoid bone. These different
phenotypes suggest that the Br mutation could affect expression of
other genes in addition to Six2. Six3 is a potential candidate, since the
gene lies close to Six2.
Craniofacial abnormalities, including brachicephaly, have been ob-
served in patients with a deletion encompassing SIX2 (Rajcan-Separovic
et al., 2007). Our ﬁndings, and the presence of SIX2 in the anterior cranial
base inhumans,may linkSIX2 tohumancongenital disorders causedbyan
abnormal growth of the cranial base.
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